FDA Approved: OZURDEX — Original Application (Allergan, Inc.)

View source ↗

Summary

FDA granted the original approval for Ozurdex (dexamethasone intravitreal implant) by Allergan for the treatment of macular edema following branch retinal vein …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Macular Edema Following Branch Retinal Vein Occlusion
• Macular Edema Following Central Retinal Vein Occlusion

Drugs mentioned

• Ozurdex (dexamethasone intravitreal implant)

Snippet

ORIG AP for OZURDEX (DEXAMETHASONE)